News

AddToAny

Google+ Facebook Twitter Twitter

Digital Pathology group

The IBMS discussion group for digital pathology is looking for new members to attend and facilitate at virtual meetings.

There are a number of leadership roles within the group to fill too, including Treasurer, Secretary and committee members.

This group offers an opportunity for biomedical scientists to share their knowledge and experience of digital pathology in the laboratory and will feature talks on all aspects of digital pathology, including implementation, safety and artificial intelligence.

Meetings will be open to all interested IBMS members and will take place online.

The group will be headed by Chloe Knowles, Specialist Biomedical Scientist at the Leeds Teaching Hospitals NHS Trust.

Chloe said: “I’d like to be able give people a place where they can come and learn and discuss how we can raise the profile of the biomedical science staff in such an important advancement for the pathology sector.”

For info, email [email protected]

Image Credit | Shuttestock

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top